Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00148304 · ClinicalTrials.gov registry record
Insulin Treatment Variation in Southwestern Diabetics
A clinical trial of Diabetes and Self-Monitoring, Blood Glucose, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 1,248
- Enrollment target
- 3
- Study locations
NCT00148304: Completed study of Diabetes and Self-Monitoring, Blood Glucose, sponsored by VA Office of Research and Development.
NCT00148304 is a study of Diabetes and Self-Monitoring, Blood Glucose that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,248 participants, below the 3,025-participant average among 338 other Diabetes trials with a reported enrollment target (59% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00148304, a study of Diabetes and Self-Monitoring, Blood Glucose, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 1,248 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to better understand disparities in insulin dosing, hemoglobin A1c, and self-reported patient self-care behaviors among non-Hispanic white, Hispanic, and African American veterans with type 2 diabetes receiving VA care.
Conditions Studied
Study Locations (3)
Arizona
- Phoenix VA Health Care System, Phoenix, AZ - Phoenix
- Southern Arizona VA Health Care System, Tucson, AZ - Tucson
New Mexico
- New Mexico VA Health Care System, Albuquerque, NM - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,248 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-06 |
What the finished NCT00148304 record still lists
NCT00148304 is an observational study that tracks outcomes without assigning an intervention. Its 1,248 participants enrollment target places it among the larger protocols in the corpus, below the 3,025-participant average among 338 other Diabetes trials with a reported enrollment target (59% lower).
The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 0 interventions.
NCT00148304 reports a single indexed study location in Arizona, New Mexico.
Frequently Asked Questions
What is clinical trial NCT00148304 about?
NCT00148304 is a clinical study titled "Insulin Treatment Variation in Southwestern Diabetics". The purpose of this study is to better understand disparities in insulin dosing, hemoglobin A1c, and self-reported patient self-care behaviors among non-Hispanic white, Hispanic, and African American veterans with type 2 diabetes receiving VA care.
What is the current status of trial NCT00148304?
This trial is currently completed. The enrollment target is 1,248 participants. The study started on 2005-09. Estimated completion is 2008-06.
What conditions does trial NCT00148304 study?
This clinical trial studies the following conditions: Diabetes, Self-Monitoring, Blood Glucose.
Who is sponsoring clinical trial NCT00148304?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00148304 being conducted?
This trial has 3 study locations across Arizona, New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00148304's enrollment target sits among peer trials
1,248 36th of 338 higher than 303 of 338 other Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Taste Bud-Derived Stem Cells in Humans
RECRUITING
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
- NCT04670874 · 1,250 participants
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- NCT04807868 · 1,250 participants
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
- NCT05995821 · 1,250 participants
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia